262825 Knowledge, attitudes and beliefs about anal cancer screening among HIV-positive women

Monday, October 29, 2012

Tracy A. Battaglia, MD, MPH , Women's Health Unit, Section of General Internal Medicine, Department of Medicine, Boston University School of Medicine, Boston, MA
Molly E. McCoy, MPH , Women's Health Unit, Section of General Internal Medicine, Department of Medicine, Boston University School of Medicine, Boston, MA
Sarah E. Caron, MPH , Women's Health Unit, Section of General Internal Medicine, Department of Medicine, Boston University School of Medicine, Boston, MA
Helen H. Mu , Obstetrics-Gynecology, Boston University School of Medicine, Boston, MA
Sharon M. Bak, MPH , Women's Health Unit, Section of General Internal Medicine, Department of Medicine, Boston University School of Medicine, Boston, MA
Amy S. Baranoski, MD , Department of Medicine, Section of Infectious Diseases, Boston University School of Medicine, Boston, MA
Karen M. Freund, MD, MPH , Associate Director for Research Collaboration, Institute for Clinical Research and Health Policy Studies, Tufts Medical Center, Boston, MA
Elizabeth Y. Chiao, MD , Section of Infectious Diseases, Baylor College of Medicine, Houston, TX
Elizabeth A. Stier, MD , Obstetrics-Gynecology, Boston University School of Medicine, Boston, MA
Background: Women with HIV are at increased risk for anal cancer; it is unknown whether women are amenable to screening. Goal: To assess knowledge, attitudes and beliefs regarding anal cancer and screening among an HIV-positive female population. Methods: English-speaking adult women presenting for HIV care at an urban safety-net hospital completed a survey using the Health Belief Model framework to measure knowledge, perceived susceptibility, perceived benefits and barriers to anal cancer screenings. History of anal cancer screening (anal cytology) was abstracted from medical records. Results: 100 women participated; mean age 45 (SD 10), 85% Black, 15% Hispanic; 32% non-US born, and 75% publicly insured. Most (75%) agreed that HPV can cause anal cancer and 58% agreed that HIV increases risk of anal cancer. However, 33% did not perceive themselves at risk. Almost all (97%) agreed having anal cytology is important, and 98% agreed screening finds abnormalities before becoming cancer. Perceived barriers to screening included: fear of sexual assault flashbacks (24%), fear of pain (22%), embarrassment (20%) and lack of social support (20%). No differences in knowledge, attitudes or beliefs of anal cancer screening were found when comparing women who participated in anal cancer screening (45%) versus those who had not. Conclusions: Women with HIV believe that anal cancer screening is important for their health. Barriers to participation that would need to be addressed in implementing a screening program include: Not perceiving themselves at risk, fear of pain, embarrassment, and limited social support.

Learning Areas:
Implementation of health education strategies, interventions and programs

Learning Objectives:
Discuss acceptability and barriers to implementing anal cancer screening in a diverse, HIV-positive population of women.

Keywords: Cancer Prevention, HIV/AIDS

Presenting author's disclosure statement:

Qualified on the content I am responsible for because: As the project manager, I am involved firsthand in the analysis and interpretation of the study data, and all dissemination activities.
Any relevant financial relationships? No

I agree to comply with the American Public Health Association Conflict of Interest and Commercial Support Guidelines, and to disclose to the participants any off-label or experimental uses of a commercial product or service discussed in my presentation.